Press Releases

Press Releases

  1. BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme

  2. BTG plc: Annual General Meeting

  3. ACCESS PTS Study Demonstrates Efficacy of EKOS® Therapy for Post-Thrombotic Syndrome

  4. New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation

  5. New study shows IO Loop™ improves patient follow-up, engagement and satisfaction following treatment with TheraSphere®

  6. SIO announces first grants in Interventional Oncology / Immuno-Oncology research programme

  7. OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  8. BTG and HealthLoop collaborate on IO Loop™, an exclusive service to connect patients and interventional oncologists throughout treatment

  9. BTG plc: Final Results 2017

  10. First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads

  11. BTG plc: close period update

  12. SnakeBite911™ Expands Free Snake Education and Snakebite Safety App to Android Devices

  13. BTG announces CE Mark Certification for DC Bead LUMI™, the First commercially available Radiopaque Drug-Eluting Bead

  14. BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

  15. BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

  16. New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians

  17. First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® system